Kubota K, Horai Y, Kushida K, Ishizaki T
Division of Clinical Pharmacology, National Medical Center, Tokyo, Japan.
J Chromatogr. 1988 Mar 4;425(1):67-75. doi: 10.1016/0378-4347(88)80007-0.
For patients with inborn errors of urea synthesis, oral administration of sodium benzoate is the usual treatment to increase the nitrogen excretion. Thus, monitoring hippuric acid and benzoic acid simultaneously in human biological fluids is considered to be clinically important. We developed a simple and accurate high-performance liquid chromatographic method for the simultaneous determination of hippuric acid and benzoic acid in human plasma and urine. This method requires no extraction step. Aliquots of urine and plasma are added to a solution of internal standard (o-chlorobenzoic acid) in acetonitrile and directly injected onto a reversed-phase column using an acidic (pH 2.7) eluent and ultraviolet detection at 235 nm. The preliminary plasma concentration-time and urinary excretion rate-time profiles of hippuric acid and benzoic acid from a healthy subject receiving small, medium and large doses of sodium benzoate are reported.
对于尿素合成先天性缺陷的患者,口服苯甲酸钠是增加氮排泄的常用治疗方法。因此,同时监测人体生物体液中的马尿酸和苯甲酸被认为具有临床重要性。我们开发了一种简单准确的高效液相色谱法,用于同时测定人血浆和尿液中的马尿酸和苯甲酸。该方法无需萃取步骤。将尿液和血浆的等分试样加入到含有内标(邻氯苯甲酸)的乙腈溶液中,使用酸性(pH 2.7)洗脱液并在235 nm处进行紫外检测,直接进样到反相柱上。报告了一名健康受试者接受小剂量、中剂量和大剂量苯甲酸钠后马尿酸和苯甲酸的初步血浆浓度-时间和尿排泄率-时间曲线。